PE-22-28

$62.50

PE-22-28 — Neurocognitive & Neuroplasticity Research

A synthetic neuroactive research peptide studied around the biology of neuroplasticity, neuronal signaling, and central nervous system communication, with particular interest in molecular pathways associated with neurological adaptation and mood-related research.

PE-22-28 is a short synthetic peptide derived from a region of spadin, a peptide associated with regulation of the TREK-1 potassium channel. Preclinical research has explored PE-22-28 in relation to TREK-1 signaling, neurogenesis, neuronal plasticity, and behavioral pathways associated with mood regulation. Research remains primarily experimental and preclinical, and PE-22-28 is not an FDA-approved medication.

Research Focus: TREK-1 Signaling • Neuroplasticity • Neurogenesis • Neuronal Communication • Mood-Related Research • Potassium Channel Biology • Central Nervous System Research

A neuroactive research peptide for those interested in the science of neuroplasticity, neuronal adaptation, TREK-1 signaling, and the molecular pathways involved in brain communication and mood-related biology.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

PE-22-28 — Neurocognitive & Neuroplasticity Research

A synthetic neuroactive research peptide studied around the biology of neuroplasticity, neuronal signaling, and central nervous system communication, with particular interest in molecular pathways associated with neurological adaptation and mood-related research.

PE-22-28 is a short synthetic peptide derived from a region of spadin, a peptide associated with regulation of the TREK-1 potassium channel. Preclinical research has explored PE-22-28 in relation to TREK-1 signaling, neurogenesis, neuronal plasticity, and behavioral pathways associated with mood regulation. Research remains primarily experimental and preclinical, and PE-22-28 is not an FDA-approved medication.

Research Focus: TREK-1 Signaling • Neuroplasticity • Neurogenesis • Neuronal Communication • Mood-Related Research • Potassium Channel Biology • Central Nervous System Research

A neuroactive research peptide for those interested in the science of neuroplasticity, neuronal adaptation, TREK-1 signaling, and the molecular pathways involved in brain communication and mood-related biology.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.